Enalapril Maleate/Felodipine

马来酸依那普利/非洛地平

Report date: 2022/01/14 13:23:58

Base Information

Drug NameEnalapril Maleate/Felodipine
Drug Alias Name非洛地平/马来酸依那普利Felodipine/Enalapril MaleateLexxel
ClassificationSmall molecules
Mechanisms of ActionVoltage-gated calcium channel blockersAngiotensin-converting enzyme inhibitors
TargetsVoltage-gated calcium channelAngiotensin-converting enzyme
Therapy Area/IndicationsHypertension
Global Approved IndicationsHypertension
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1996/12/27
Country/TerritoryUnited States
CombinationsYes Enalapril MaleateFelodipine
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstrazeneca Plc
Active IndicationsN/A
Inactive IndicationsHypertension

Other Information

ATC CodeN/A
Related LinksN/A